Find clinical trials for type 1 diabetes. Search for type 1 diabetes clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 2,477
Active & ResponsiveNew
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
for
Type 1 Diabetes, Type 2 Diabetes
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 25 - 70
Code: NCT06976619
Phase2, Recruiting
Active & ResponsiveNew
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
for
Acute Biphenotypic Leukemia, Acute Leukemia,
Location: Los Angeles CA, Iowa City IA, Cleveland OH, Portland OR,
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 0 - 26
Code: NCT03779854
Phase2, Recruiting
Active & ResponsiveNew
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
for
Acute Myeloid Leukemia, Pediatric AML
Location: Houston TX
Sponsor: Joanna Yi
Sex: All
Age: 0 - 30
Code: NCT07059975
Early_phase1, Recruiting
Active & ResponsiveNew
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
for
Schizophrenia
Location: Omaha NE, Fort Mill SC
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07101094
Recruiting
Active & ResponsiveNew
Single Shot Exparel vs Catheters in Lower Extremity Trauma
for
Fracture Dislocation of Ankle Joint, Fracture Leg,
Location: Washington D.C. DC
Sponsor: George Washington University
Sex: All
Age: 18+
Code: NCT07221019
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Fairfax VA
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07111520
Phase1, Phase2, Recruiting
Active & ResponsiveNew
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase2, Phase3, Recruiting
Active & ResponsiveNew
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
for
Chronic Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06817720
Phase2, Recruiting
Active & ResponsiveNew
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma